Name: | Cefuroxime |
---|---|
PubChem Compound ID: | 2659 |
Description: | Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. |
Molecular formula: | C16H16N4O8S |
Molecular weight: | 424.386 g/mol |
Synonyms: |
DivK1c_000159; Spectrum2_000706; KBio1_000159; KBio3_002603; KBio2_001903; Spectrum4_000156; Spectrum_001423; SPBio_000891; Spectrum3_001492; KBio2_007039.
show more » |
Name: | Cefuroxime |
---|---|
Name (isomeric): | DB01112 |
Drug Type: | small molecule |
Description: | Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. |
Synonyms: |
Cefuroxim; Cefuroximum [INN-Latin]; Cefuroxime [USAN:BAN:INN]; Cefuroximo [INN-Spanish]
|
Brand: | Kefzol, Velosef, Cefzil, Zinat, Rocephin, Zinnat, Duricef, Elobact, Mefoxin, Cephuroxime, Monocid, Cefotan, Ancef, Cefuril, Cefobid, Kerurox, Ceftin, Cedax, Maxipime, Cefizox, Mandol, Cefurax, Biofuroksym, Sharox, Zinacef, Cepazine, Kefurox, Oraxim |
Category: | Cephalosporins, Anti-Bacterial Agents |
CAS number: | 55268-75-2 |
Indication: | For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections. |
---|---|
Pharmacology: |
Cefuroxime is a β-lactam type antibiotic. More specifically, it is a second-generation cephalosporin. Cephalosporins work the same way as penicillins: they interfere with the peptidoglycan synthesis of the bacterial wall by inhibiting the final transpeptidation needed for the cross-links. This effect is bactericidal. Cefuroxime is effective ag...
show more » |
Mechanism of Action: |
Cefuroxime, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefuroxim...
show more » |
Absorption: | Absorbed from the gastrointestinal tract. Absorption is greater when taken after food (absolute bioavailability increases from 37% to 52%). |
Protein binding: | 50% to serum protein |
Biotransformation: | The axetil moiety is metabolized to acetaldehyde and acetic acid. |
Half Life: | Approximately 80 minutes following intramuscular or intravenous injection. |
Toxicity: | Allergic reactions might be expected, including rash, nasal congestion, cough, dry throat, eye irritation, or anaphylactic shock. Overdosage of cephalosporins can cause cerebral irritation leading to convulsions. |
Affected organisms: | Enteric bacteria and other eubacteria |
Food interaction: |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug interaction: |
|